Janus Henderson Group PLC Mereo Biopharma Group PLC Transaction History
Janus Henderson Group PLC
- $182 Billion
- Q2 2024
A detailed history of Janus Henderson Group PLC transactions in Mereo Biopharma Group PLC stock. As of the latest transaction made, Janus Henderson Group PLC holds 7,880,882 shares of MREO stock, worth $33.7 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
7,880,882
Previous 5,120,573
53.91%
Holding current value
$33.7 Million
Previous $16.9 Million
67.91%
% of portfolio
0.02%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding MREO
# of Institutions
85Shares Held
102MCall Options Held
121KPut Options Held
208K-
Rubric Capital Management LP New York, NY15.3MShares$65.5 Million1.63% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA11.8MShares$50.5 Million0.08% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD9.28MShares$39.7 Million1.04% of portfolio
-
Mangrove Partners New York, NY8.75MShares$37.5 Million3.54% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY6.71MShares$28.7 Million0.51% of portfolio
About Mereo Biopharma Group plc
- Ticker MREO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,986,000
- Market Cap $535M
- Description
- Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...